H.R. 4030

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 4030 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 4030 To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 17, 2025 Mr. Dunn of Florida (for himself, Mr. Soto, and Mr. Bean of Florida) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Treatment Continuity Act of 2025''. SEC. 2. PRIORITY SUBSTANCE USE DISORDER AND SERIOUS MENTAL ILLNESS TREATMENT NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE. (a) In General.--Section 509 of the Public Health Service Act (42 U.S.C. 290bb-2) is amended-- (1) in the section heading, by inserting ``and serious mental illness'' after ``substance use disorder''; (2) in subsection (a)-- (A) in the matter preceding paragraph (1), by inserting ``and serious mental illness'' after ``substance use disorder''; and (B) by striking paragraphs (1) through (3) and inserting the following: `` ``(1) access to long-acting injectable medications that are approved by the Food and Drug Administration for the treatment of individuals with substance use disorders or serious mental illness; ``(2) lab testing and supportive counseling for substance use disorder and serious mental illness; and ``(3) training on the use of long-acting injectable medications for the purposes described in paragraph (1), in combination with associated clinical services such as counseling.''; (3) in subsection (b)-- (A) in the subsection heading, by inserting ``and Serious Mental Illness'' after ``Substance Use Disorder''; and (B) in paragraphs (1) and (2), by inserting ``and serious mental illness'' after ``substance use disorder''; (4) by striking subsections (d) and (e) and inserting the following: ``(d) Annual Report to Congress.--Not later than 1 year after the date of enactment of the Treatment Continuity Act of 2025, and annually thereafter during the term of the program under this section, the Secretary shall transmit to Congress a report on the outcomes of such program, including completed or substantial progress toward treatment requirements based on clinician assessment.''; and (5) by redesignating subsection (f) as subsection (e). (b) Applicability.--The amendments made by this section shall apply to grants made under section 509 of the Public Health Service Act after the date of the enactment of this Act. <all>